ODX.L Regulatory News (ODX)

Omega Diagnostics Group PLC

("Omega" or "the Company" or the "Group")

Investor Evening

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces it will be hosting an investor evening for all investors on Monday 21 May 2018.

Colin King, CEO will give an update on the Group's core business activities following the recent announcement of a strategic review. He will be joined by Kieron Harbinson, FD, and Jag Grewal, Group Sales and Marketing Director. The presentation and Q&A will last approximately 60 minutes.

The event will take place in the Copper Bar, upstairs at Balls Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.30pm for a 4.45pm start. This will be followed by light refreshments, and a chance to network.

The presentation slides will be available on the Company website shortly after the event. No new information will be disclosed. 

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email omega@walbrookpr.com.

Contacts: